Form 4: TransDigm Group INC: Co-Chief Operating Officer Michael Lisman Executes Stock Options and Sells Shares

Sentiment:

SEC Form 4


Michael Lisman, Co-Chief Operating Officer of TransDigm Group INC, exercised stock options and sold shares of common stock on February 23 and 26, 2024.

Summary

  • On February 23 and 26, 2024, Michael Lisman, the Co-Chief Operating Officer of TransDigm Group INC, exercised stock options to acquire 8,000 shares of common stock on each day at a price of $347.17 per share.
  • Following the exercise of these options, Lisman sold shares of common stock in multiple transactions at prices ranging from approximately $1,187.39 to $1,204.14.
  • The sales on February 23, 2024, involved the disposal of 929, 1,024, 1,011, 1,987, 1,426, 1,412 and 211 shares.
  • The sales on February 26, 2024, involved the disposal of 162, 372, 161, 308, 480, 1,074, 901, 1,132, 795, 508, 826, 380, 636, 129, 133 and 3 shares.
  • After these transactions, Lisman directly owns no shares, but indirectly owns 0 shares through the Michael Lisman Declaration of Trust dated January 31, 2023.
  • He also indirectly owns 92,000 derivative securities (stock options) through the same trust.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the document simply reports transactions. Option exercises and sales are a normal part of executive compensation.

Industry Context

Insider transactions are routinely monitored by investors as they can provide signals, though not always definitive, about management's perspective on the company's valuation and future prospects. Option exercises and subsequent sales are common for executives to diversify their holdings and realize compensation.

Comparison to Industry Standards

  • Comparing Lisman's transactions to those of executives at similar aerospace and defense companies like Boeing, Lockheed Martin, or RTX Corporation would require analyzing their respective Form 4 filings.
  • Generally, the scale of these transactions is typical for C-level executives at companies of TransDigm's size.
  • Benchmarking against industry averages for executive compensation and stock ownership can provide further context.

Stakeholder Impact

  • The transactions may have a minor impact on shareholders due to the increased supply of shares in the market.
  • The impact on employees, customers, suppliers, and creditors is likely negligible.

Key Dates

DateDescription
January 31, 2023Date of Michael Lisman Declaration of Trust
September 30, 2019Date exercisable for stock options
February 23, 2024Date of stock option exercise and share sales
February 26, 2024Date of stock option exercise and share sales
February 27, 2024Date of Form 4 signature
November 05, 2028Expiration date for stock options

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.